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`    Experimental design
1.   Sample size
Describe how sample size was determined. The experiments described in this exploratory study were done for the first time. 
No pre-specified effect size could be determined a priori. 
For MS, in general, two replicates are acceptable if the overlap between them is 
good (e.g. r2 greater than or equal to 0.80). In this study we used a minimum of 
two replicates per proteome and up to 6 replicates. We had excellent 
reproducibility between replicates, with r2 greater than 0.90. 
 
 
 
 
 
 
2.   Data exclusions
Describe any data exclusions. No data were excluded from the study.
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
The isolation of specific proteomes was reproducible as is shown in the paper and 
described above. Nevertheless due to the several steps of the purification protocol, 
the purification of some samples failed and there was no mass spec analysis. 
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
As a general rule, mice (wt or transgenic) were all exposed to the same treatment. 
In the case of EE and HC experiments mice were randomly distributed in each of 
the cage types. 
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
Investigators were not blinded.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
ImageJ64. Prism 6. Origin 2015G. MaxQuant 1.5.3.8. Perseus 1.5.5.3. 
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
No unique materials are used. 
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
Mouse anti-biotin (IF and IB, 1:1000, Sigma, cat:033700). Rabbit anti-biotin (IF and 
IB, 1:1500, Cell Signaling, cat:5567). Rabbit anti-GFP (IF and IB 1:750, Invitrogen, 
cat:A11122). Chicken anti-GFP (IF, 1:500; IB: 1:1000; Aves,cat:1020). Gp anti-MAP2 
(1:1000, SYSY,cat:188004).  
Antibodies used for the PLA experiments: rabbit anti-Lamin 1:1000 (abcam, 
cat:ab16048), rabbit anti-Debrin 1:500 (sigma, cat:d3816), rabbit anti-GluA1 1:500 
(abcam, cat:ab31232). Mouse anti-far red (1:100, abcam, cat:ab52060 ).  
Secondary antibodies 
Goat anti-chicken Alexa 647 (IF, 1:750; IB, 1:7500; Invitrogen, a21449). Goat anti-
rabbit Rhodamine RRX (IF, 1:800, Jackson laboratory, cat:711295152). Goat anti-
rabbit FITC (IF, 1:800, Jackson laboratory, cat:111095003). Goat anti-mouse or 
anti-rabbit  IR680 or IR800 (IB, 1:10.000, Licor,cat:296-32213 and 296-32211). 
Antibody specificity was evaluated using the proper negative controls.
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10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. Hek, HeLa and Cos7 were obtained from ATCC.
b.  Describe the method of cell line authentication used. None of the lines have been authenticated.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
Lack of cell line contamination with mycoplasma was checked by PCR (eMyco 
detection kit, Intron Biotechnology).
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
`    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
All the mice used in this study were C57BL/6 from Jackson Laboratory. Animals 
used were 6 weeks old at the beginning of the experiments. Both males and 
Females were used.  
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
Study did not involved humans.
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